Khoa Nathan V. Tran

FDA investigator

Appears on 21 documents from 2021 to 2026, most often at sites in California. Most often cites testing and approval or rejection of components, drug product containers, and closures (21 CFR 211.84).

21
Documents on file
5.8
Observations per 483
2021
First seen
2026
Most recent

What they cite most

From 127 observations

Activity by year

2021: 3, 2022: 3, 2023: 3, 2024: 4, 2025: 6, 2026: 2

Where

California 10 · France 2 · Idaho 2 · United Kingdom 2 · China 1 · Greece 1

Is Khoa Nathan V. Tran coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

21 documents, newest first
FirmOpen
483 Excel VisionJan 22, 2026 · Annonay, France
Warning letter Excel VisionJan 22, 2026 · Annonay, France
483 Pharmathen International S.A. Industrial Park, Sapes Rodopi PrefectureNov 21, 2025 · Rodopi, Greece
483 ORGANON PHARMA (UK) LIMITEDJun 13, 2025 · Cramlington, United Kingdom
483 Ajinomoto Althea, IncMay 9, 2025 · San Diego, California
483 International Isotopes IncApr 25, 2025 · Idaho Falls, Idaho
483 Topiderm, Inc.Mar 7, 2025 · North Amityville, New York

About this profile

What does Khoa Nathan V. Tran inspect?

Khoa Nathan V. Tran appears on 21 documents on file covering 19 sites, most often in California.

What do they cite most often?

21 CFR 211.84 (testing and approval or rejection of components, drug product containers, and closures), followed by 21 CFR 211.192 and 21 CFR 211.67(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Khoa Nathan V. Tran is dated Jan 22, 2026.